These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17924566)

  • 1. Mycophenolate mofetil therapy for refractory inflammatory bowel disease.
    Palaniappan S; Ford AC; Greer D; Everett SM; Chalmers DM; Axon AT; Hamlin PJ
    Inflamm Bowel Dis; 2007 Dec; 13(12):1488-92. PubMed ID: 17924566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate mofetil therapy in the management of inflammatory bowel disease--a retrospective case series and review.
    Smith MR; Cooper SC
    J Crohns Colitis; 2014 Aug; 8(8):890-7. PubMed ID: 24507162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is mycophenolate mofetil an effective alternative in azathioprine-intolerant patients with chronic active Crohn's disease?
    Miehsler W; Reinisch W; Moser G; Gangl A; Vogelsang H
    Am J Gastroenterol; 2001 Mar; 96(3):782-7. PubMed ID: 11280551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: a 12-month pilot study.
    Orth T; Peters M; Schlaak JF; Krummenauer F; Wanitschke R; Mayet WJ; Galle PR; Neurath MF
    Am J Gastroenterol; 2000 May; 95(5):1201-7. PubMed ID: 10811328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of mycophenolate mofetil in inflammatory bowel disease.
    Tan T; Lawrance IC
    World J Gastroenterol; 2009 Apr; 15(13):1594-9. PubMed ID: 19340901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil in refractory inflammatory bowel disease.
    Ford AC; Towler RJ; Moayyedi P; Chalmers DM; Axon AT
    Aliment Pharmacol Ther; 2003 Jun; 17(11):1365-9. PubMed ID: 12786630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel disease.
    Fellermann K; Steffen M; Stein J; Raedler A; Hämling J; Ludwig D; Loeschke K; Stange EF
    Aliment Pharmacol Ther; 2000 Feb; 14(2):171-6. PubMed ID: 10651657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mycophenolate mofetil in refractory Crohn's disease after failure of treatments by azathioprine or methotrexate].
    Hafraoui S; Dewit O; Marteau P; Cosnes J; Colombel JF; Modigliani R; Cortot A; Lémann M
    Gastroenterol Clin Biol; 2002 Jan; 26(1):17-22. PubMed ID: 11938035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease.
    Neurath MF; Wanitschke R; Peters M; Krummenauer F; Meyer zum Büschenfelde KH; Schlaak JF
    Gut; 1999 May; 44(5):625-8. PubMed ID: 10205197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of mycophenolate mofetil in patients failing 6-mercaptopurine or azathioprine therapy for Crohn's disease.
    Hassard PV; Vasiliauskas EA; Kam LY; Targan SR; Abreu MT
    Inflamm Bowel Dis; 2000 Feb; 6(1):16-20. PubMed ID: 10701145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of steroid refractory inflammatory bowel disease (IBD) with mycophenolate mofetil (MMF).
    Florin TH; Roberts RK; Watson MR; Radford-Smith GL
    Aust N Z J Med; 1998 Jun; 28(3):344-5. PubMed ID: 9673748
    [No Abstract]   [Full Text] [Related]  

  • 12. Toxicity of mycophenolate mofetil in patients with inflammatory bowel disease.
    Skelly MM; Logan RF; Jenkins D; Mahida YR; Hawkey CJ
    Inflamm Bowel Dis; 2002 Mar; 8(2):93-7. PubMed ID: 11854606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil in patients with Crohn's disease.
    Fickert P; Hinterleitner TA; Wenzl HH; Aichbichler BW; Petritsch W
    Am J Gastroenterol; 1998 Dec; 93(12):2529-32. PubMed ID: 9860419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
    Baumgart DC; Pintoffl JP; Sturm A; Wiedenmann B; Dignass AU
    Am J Gastroenterol; 2006 May; 101(5):1048-56. PubMed ID: 16573777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
    Transplantation; 1996 Mar; 61(5):722-9. PubMed ID: 8607174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical therapies for ulcerative colitis and Crohn's disease.
    Baert FJ; Rutgeerts PJ
    Curr Gastroenterol Rep; 2000 Dec; 2(6):446-50. PubMed ID: 11079045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis.
    Sahin GM; Sahin S; Kiziltas S; Masatlioglu S; Oguz F; Ergin H
    Ren Fail; 2008; 30(9):865-9. PubMed ID: 18925525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Azathioprine in inflammatory bowel disease].
    Leite S; Ribeiro JM; Lima SC; Barroso S; Cotter J
    Acta Med Port; 2009; 22(1):33-40. PubMed ID: 19341591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse Model.
    Lv QK; Liu JX; Li SN; Gao YJ; Lv Y; Xu ZP; Huang BX; Xu SY; Yang DX; Zeng YL; Liu DF; Wang W
    Int J Mol Sci; 2015 Nov; 16(11):26654-66. PubMed ID: 26561804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.